These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24925057)

  • 1. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum.
    Murakami T; Mitomi H; Saito T; Takahashi M; Sakamoto N; Fukui N; Yao T; Watanabe S
    Mod Pathol; 2015 Jan; 28(1):146-58. PubMed ID: 24925057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
    Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
    Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic diagnosis of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
    Murakami T; Sakamoto N; Nagahara A
    World J Gastroenterol; 2018 Aug; 24(29):3250-3259. PubMed ID: 30090005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps.
    Hashimoto T; Yamashita S; Yoshida H; Taniguchi H; Ushijima T; Yamada T; Saito Y; Ochiai A; Sekine S; Hiraoka N
    Am J Surg Pathol; 2017 Sep; 41(9):1188-1197. PubMed ID: 28614199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.
    Cappellesso R; Lo Mele M; Munari G; Rosa-Rizzotto E; Guido E; De Lazzari F; Pilati P; Tonello M; Farinati F; Realdon S; Fassan M; Rugge M
    Pathol Res Pract; 2019 May; 215(5):957-962. PubMed ID: 30738693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of APC in WNT pathway activation in serrated neoplasia.
    Borowsky J; Dumenil T; Bettington M; Pearson SA; Bond C; Fennell L; Liu C; McKeone D; Rosty C; Brown I; Walker N; Leggett B; Whitehall V
    Mod Pathol; 2018 Mar; 31(3):495-504. PubMed ID: 29148535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
    Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathological and molecular analysis of 200 traditional serrated adenomas.
    Bettington ML; Walker NI; Rosty C; Brown IS; Clouston AD; McKeone DM; Pearson SA; Klein K; Leggett BA; Whitehall VL
    Mod Pathol; 2015 Mar; 28(3):414-27. PubMed ID: 25216220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features, diagnosis, and treatment of sessile serrated adenoma/polyp with dysplasia/carcinoma.
    Murakami T; Sakamoto N; Nagahara A
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1685-1695. PubMed ID: 31158302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
    Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
    Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
    Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct histopathological characteristics in colorectal submucosal invasive carcinoma arising in sessile serrated adenoma/polyp and conventional tubular adenoma.
    Murakami T; Mitomi H; Yao T; Saito T; Shibuya T; Sakamoto N; Osada T; Watanabe S
    Virchows Arch; 2018 Mar; 472(3):383-393. PubMed ID: 28929387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
    García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
    Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.